Sensus/$SRTS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sensus
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Ticker
$SRTS
Sector
Primary listing
Employees
60
Headquarters
Website
Sensus Metrics
BasicAdvanced
$45m
-
-$0.48
1.09
-
Price and volume
Market cap
$45m
Beta
1.09
52-week high
$5.92
52-week low
$2.66
Average daily volume
85k
Financial strength
Current ratio
7.268
Quick ratio
3.738
Long term debt to equity
0.307
Total debt to equity
0.894
Profitability
EBITDA (TTM)
-11.623
Gross margin (TTM)
37.74%
Net profit margin (TTM)
-34.50%
Operating margin (TTM)
-53.34%
Effective tax rate (TTM)
31.79%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
-13.44%
Return on equity (TTM)
-15.77%
Valuation
Price to revenue (TTM)
1.982
Price to book
0.99
Price to tangible book (TTM)
0.99
Growth
Revenue change (TTM)
-42.94%
Earnings per share change (TTM)
-530.72%
3-year revenue growth (CAGR)
-15.70%
10-year revenue growth (CAGR)
7.07%
3-year earnings per share growth (CAGR)
8.35%
10-year earnings per share growth (CAGR)
42.79%
Sensus News
AllArticlesVideos
Sensus Healthcare Q1 Earnings Call Highlights
MarketBeat·1 month ago
Sensus Healthcare Announces Amicable Resolution of Commercial Dispute with SkinCure Oncology
Business Wire·1 month ago
Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs